Retrospective observation on trabeculectomy of primary congenital glaucoma by applying biological amniotic membranes soaked with 5-fluorouracil
- 86 Downloads
To report our experience on treatment of primary congenital glaucoma with trabeculectomy in combination with biological amniotic membranes soaked with 5-fluorouracil.
This is a retrospective study. Thirty primary congenital glaucoma (PCG) patients (41 eyes) were treated with trabeculectomy in combination with biological amniotic membranes soaked with 5-fluorouracil before operation and followed up for 2.75 ± 1.35 years in average ranging from 1.2 to 5.3 years (Group A). In addition, 22 PCG patients (32 eyes) treated with mitomycin C-trabeculectomy were selected as control and followed up for 2.3 ± 1.25 years in average ranging from 1.4 to 5.1 years (Group B).
Patients in Group A were 4.74 ± 2.13 years old. After treatment, their mean intraocular pressure decreased from preoperative 38.8 ± 11.3–17.6 ± 8.2 mmHg at 12 months of postoperation (P = 0.0000). At 12 months of follow-up, the intraocular pressure was less than 13 mmHg in 8 eyes (19.5%), between 17 and 13 mmHg in 15 eyes (36.6%), between 21 and 17 mmHg in 12 eyes (29.3%) and more than 21 mmHg in 6 eyes (14.6%). The overall success rate was 85.4%, and total complication rate was 17.1%. By comparison, the overall success rate and total complication rate were 87.5 and 34.4%, respectively, at 12 months of follow-up for patients in Group B. Although the overall success rate was not significantly different between Groups A and B (P = 0.1203) at the end of follow-up, the total complication rate was significantly decreased in Group A (P = 0.0419).
Application of trabeculectomy in combination with biological amniotic membranes soaked with 5-fluorouracil can be an effective surgical treatment method for primary congenital glaucoma patients.
KeywordsPrimary congenital glaucoma Trabeculectomy Amniotic membrane 5-fluorouracil
This study was supported by the Jinan City Health Science and Technology Development Plan (2008-13), the Jinan City Clinical Technology Development Plan (201503023) and the Shandong Provincial Science and Technology Department Key Research and Development Project (2015GSF118066).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Cai Y, Li MY, Sheng YY, Liu LN (2004) Long-term effect of trabeculectomy for treatment primary congenital glaucoma. Chin J Ophthalmol 11:733–736Google Scholar
- 5.Green E, Wilkins M, Bunce C, Wormald R (2014) 5-fluorouracil for glaucoma surgery. Cochrane Database Syst Rev 19:1–33Google Scholar
- 6.Xue X, Gao Y (2013) Clinical observation of bio-amnion implantation used in combined trabeculectomy for refractory glaucoma. Int Eye Sci 13:944–946Google Scholar
- 8.Lu R, Ji J (2005) Application of grafts in trabeculectomy of Glaucoma. Sect Ophthalmol Foreign Med Sci 29:395–399Google Scholar
- 11.Qiao CY, Tang X, Wang NL, Sun L, Zhang SX (2009) The correlation of clinical feature in primary congenital glaucoma. Chin J Pract Ophthalmol 27:969–972Google Scholar
- 17.Han D (2012) Clinical treatment research of primary congenital glaucoma. Int J Ophthalmol 12:644–646Google Scholar
- 18.Wang XB, Liu LM, Tang GX, Chen H, Guo JX, Lu WS (2011) Observations of efficacy on external trabecular incision in combination with trabeculectomy for treatment primary congenital glaucoma. Chin J Pract Ophthalmol 29:255–257Google Scholar
- 26.Zhang CM, Guo BL, Wang JR, Liu W, Sun Y (2010) Application of anti-proliferative drugs soaked biological amniotic membrane in trabeculectomy. Recent Adv Ophthalmol 30:144–146Google Scholar